Recent Updates
Recently added Catalysts
ABCL Positive Sentiment

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

Friday, May 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AbCellera Biologics Inc. announced its participation in upcoming investor conferences scheduled for May and June 2026. The company will provide live audio webcasts of its presentations, which will also be available for replay afterward. AbCellera specializes in developing first-in-class antibody-based therapies across various medical fields.
Price reaction · baseline $4.82 (2026-05-07 close) · hit pre-market · 1 other ABCL headline(s) in the window, move may be shared
day 0 close
+8.7%
day 1 · peak
+8.9%
day 3
-1%

Market Sentiment Analysis

POSITIVE FACTORS

  • AbCellera is actively engaging with investors through presentations.
  • The company is focused on innovative antibody-based medicines.
  • Webcasts provide accessible information for stakeholders.

Full Press Release Details

VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:
A live audio webcast of each presentation may be accessed through a link that will be posted onAbCellera’s Investor Relations websitecloser to date. A replay will be available through the same link following the presentation.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women’s health, immunology, oncology, and more. For more information, please visitwww.abcellera.com.
InquiriesMedia: Tiffany Chiu;media@abcellera.com, +1(236)521-6774Partnering: Murray McCutcheon, Ph.D.;partnering@abcellera.com, +1(604)559-9005Investor Relations: Peter Ahn;ir@abcellera.com, +1(778)729-9116

Frequently Asked Questions

When will AbCellera present at investor conferences?

AbCellera will present at investor conferences in May and June 2026.

How can I access the presentations?

Presentations will be available via live audio webcasts on AbCellera's Investor Relations website.

What is AbCellera's focus area?

AbCellera focuses on developing first-in-class antibody-based medicines.

Will there be replays of the presentations?

Yes, replays of the presentations will be available after the live webcasts.

ShareAdd on Google
Tags: ABCL Viatris Investor Conferences Healthcare AbCellera investor conferences biotechnology antibody-based medicines clinical-stage
Last updated: May 8, 2026

Biotech snapshot

Cash runway
$540M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ABCL575Phase 1
Healthy Volunteers →